Building Better and More Affordable Vaccines

Thomas Rademacher, co-founder and CEO of Emergex Vaccines, discusses the company’s platform technologies, the manufacturing advantages they offer, and its pursuit of universal coronavirus and influenza vaccines that work across variants.